Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RITUXIMAB-ABBS Cause Intentional dose omission? 196 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 196 reports of Intentional dose omission have been filed in association with RITUXIMAB-ABBS. This represents 4.5% of all adverse event reports for RITUXIMAB-ABBS.

196
Reports of Intentional dose omission with RITUXIMAB-ABBS
4.5%
of all RITUXIMAB-ABBS reports
14
Deaths
76
Hospitalizations

How Dangerous Is Intentional dose omission From RITUXIMAB-ABBS?

Of the 196 reports, 14 (7.1%) resulted in death, 76 (38.8%) required hospitalization, and 7 (3.6%) were considered life-threatening.

Is Intentional dose omission Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-ABBS. However, 196 reports have been filed with the FAERS database.

What Other Side Effects Does RITUXIMAB-ABBS Cause?

Off label use (2,167) Intentional product use issue (273) Dyspnoea (208) Pain (205) Rheumatoid arthritis (202) Fatigue (195) Drug ineffective (186) Hypertension (183) Infusion related reaction (183) Rash (183)

What Other Drugs Cause Intentional dose omission?

DUPILUMAB (2,269) CERTOLIZUMAB PEGOL (1,253) ADALIMUMAB (845) TOFACITINIB (845) INFLIXIMAB (815) ABALOPARATIDE (623) ETANERCEPT (615) AMBRISENTAN (595) SODIUM OXYBATE (580) CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (518)

Which RITUXIMAB-ABBS Alternatives Have Lower Intentional dose omission Risk?

RITUXIMAB-ABBS vs RITUXIMAB-ARRX RITUXIMAB-ABBS vs RITUXIMAB-PVVR RITUXIMAB-ABBS vs RIVAROXABAN RITUXIMAB-ABBS vs RIVASTIGMINE RITUXIMAB-ABBS vs RIVOTRIL

Related Pages

RITUXIMAB-ABBS Full Profile All Intentional dose omission Reports All Drugs Causing Intentional dose omission RITUXIMAB-ABBS Demographics